UnitedHealth Discontinues Medicare Advantage Plans Impacting Thousands

UnitedHealth Group has decided to discontinue several of its Medicare Advantage plans, impacting approximately 390,000 enrollees by 2027, as announced by a company spokesperson.

This significant move will reverberate across the industry, affecting more than a million seniors overall. UnitedHealth's decision is set against a backdrop where Humana also plans to adjust its offerings, impacting roughly 600,000 members. The recent announcement is part of a broader industry shift as insurers reassess their Medicare Advantage plan portfolios in response to evolving regulatory and market dynamics.

Impact on Beneficiaries and Strategic Shifts

Notifications to affected UnitedHealthcare policyholders were dispatched on October 2. The company, which had reported Medicare Advantage enrollment of 7.565 million as of June 2026, is undergoing a strategic transformation. Last year, UnitedHealth discontinued over 100 plans, covering about 600,000 members, mainly PPOs. These changes emphasize the company's focus on sustainability and competitive positioning in selected regions.

During the Wells Fargo healthcare conference, UnitedHealth CFO Wayne DeVeydt noted that benefit redesign efforts would lead to more competitive products in 2026. A Leerink report underscored that UnitedHealthcare terminated approximately 13% of its plans in 18 states, expecting some benefit reductions. This restructuring suggests a concentrated approach to enhancing the value offered to remaining beneficiaries, likely driven by regulatory constraints and market competitiveness.

Regulatory Environment and Financial Projections

A crucial aspect for insurers is the regulatory landscape. Early 2027 saw CMS propose a minimal 0.09% rate increase, later modified to 2.48%. While this adjustment reflects regulatory challenges, UnitedHealth remains optimistic about its financial trajectory. Analysts predict a slight dip in fourth-quarter earnings per share (EPS) to $2.10 from $2.11 the previous year, as the company invests heavily in plans and commission strategies.

The company's medical care ratio guidance stands at 88.1%, indicating a rise from the previous year. This increase accommodates projected medical expenses of $148.8 billion against $174.5 billion in premiums. Despite these projections, favorable reserve developments from 2026 services have buoyed financial expectations.

Looking to the Future

UnitedHealth's long-term financial outlook anticipates revenue growth from approximately $447 billion in 2026 to roughly $557 billion by 2030, with EPS expected to increase significantly. However, the reduction in Medicare Advantage membership poses a challenge for sustaining future revenue growth, emphasizing the need for efficiency and margin management.

As the open enrollment period between October 15 and December 7 looms, industry professionals are keeping a close eye on the company's next moves. A keen focus on maintaining a significant market presence, enhancing star ratings, and managing operational intricacies will be crucial for navigating the regulatory landscape and achieving strategic goals.